The effect of fish-oil supplementation on antenatal and postpartum depression: a randomized controlled trial
The effect of fish-oil supplementation on antenatal and postpartum depression: a randomized controlled trial
Azizeh Farshbaf-Khalili1 Sakineh Mohammad-Alizadeh2 Zahra Fardiazar3 Ahad Farshbaf-Khalili4 Fatemeh Mohammadi,5 Alireza Ostadrahimi 6
1) 1- Student of PhD by research, Faculty of Nursing and Midwifery, Tabriz Health Services Management Research Center, Tabriz University of Medical Sciences Tabriz ,Iran.
2) 2- Associate professor, Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, IR Iran
3) 3- Professor, Department of Obstetrics and Gynecology, Tabriz University of Medical sciences, Tabriz, Iran.
4) 4- Psychiatrists, 29 Bahman Hospital, Tabriz, Iran
5) 5- BSc in midwifery, Health Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
6) 6- Professor, Department of Biochemical and Nutritional therapy, Faculty of Nutrition, Research Center of NPMC, Tabriz University of Medical Sciences, Tabriz, IR Iran. Corresponding Author. E-mail:
IOI Code
:
XYCC-ABCEC
Publication :
International Conference on Science and Engineering(icesconf.com)
Abstract :
Introduction:
The use of fish oil supplements during pregnancy has been studied as a potential strategy for the prevention of postpartum depression. However, information about the effects of omega-3 fatty acids on perinatal depression is inconsistent.
Objective: to evaluate the effect of fish oil supplementation on antenatal and postpartum depression.
Study Design: This was a randomized, double-blind, placebo-controlled, multi-centre trial. 150 eligible pregnant women aged 18-35 recruited from Feburary 2014 to April 2015 in Tabriz, Iran.
Participants assigned to receive either 1000 mg fish oil supplements containing 180 mg eicosapentaenoic acid and 120mg docosahexanoic acid or placebo from 16-20 weeks of gestation to 1 month after giving birth.Eligible subjects completed the Edinburgh Postnatal Depression Scale at enrollment, 26–30 weeks, 35–37 weeks, and at 30-45 days’ postpartum and mean depression score calculated at these timepoints. DHA and EPA Serum levels were analyzed at entry. Primary outcomes were mean depression score at 35-37 weeks and postpartum period. The statistical analysis was intent-to-treat.
Results: A total of 150 women were included, and none was lost to follow up. There were significant differences between groups at 35-37 weeks (adjusted MD = -1.3; [95% CI -2.5 to -0.05]). The mean score of depression during pregnancy and postpartum significantly decreased within the fish oil group (p<0.05) but it was not significant in the placebo group. There were no differences between groups after supplementation at 26-30 weeks and 30-45 days postpartum.
Conclusions: According to results, it seems that women especially in low to middle income countries may benefit from daily fish oil supplements during pregnancy. However, further studies are required to confirm this.
Keywords : fish oil antenatal depression postpartum depression iran